Independent Advisor Alliance Buys Shares of 60,661 OR Royalties Inc. $OR

Independent Advisor Alliance bought a new stake in OR Royalties Inc. (NYSE:OR) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 60,661 shares of the basic materials company’s stock, valued at approximately $2,147,000.

Other hedge funds have also recently made changes to their positions in the company. Assetmark Inc. purchased a new position in shares of OR Royalties during the 4th quarter worth approximately $36,000. Caitlin John LLC purchased a new position in shares of OR Royalties during the 3rd quarter worth approximately $78,000. Eagle Global Advisors LLC purchased a new position in shares of OR Royalties during the 3rd quarter worth approximately $206,000. Merit Financial Group LLC purchased a new position in shares of OR Royalties during the 3rd quarter worth approximately $215,000. Finally, Flow Traders U.S. LLC purchased a new position in shares of OR Royalties during the 3rd quarter worth approximately $217,000. Hedge funds and other institutional investors own 68.52% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on OR. Wall Street Zen cut shares of OR Royalties from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 11th. Scotiabank increased their price objective on shares of OR Royalties from $41.00 to $51.00 and gave the stock a “sector perform” rating in a research report on Monday, January 26th. Zacks Research cut shares of OR Royalties from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, March 31st. TD Securities reaffirmed a “hold” rating on shares of OR Royalties in a research report on Monday, February 23rd. Finally, Canadian Imperial Bank of Commerce reaffirmed an “outperform” rating on shares of OR Royalties in a research report on Wednesday, February 4th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, OR Royalties currently has a consensus rating of “Moderate Buy” and a consensus target price of $46.50.

OR Royalties Stock Down 2.3%

OR Royalties stock opened at $38.30 on Friday. The firm has a market cap of $7.18 billion, a PE ratio of 28.58 and a beta of 0.71. OR Royalties Inc. has a 52-week low of $22.63 and a 52-week high of $48.06. The company’s 50 day moving average is $39.14 and its two-hundred day moving average is $38.30.

OR Royalties (NYSE:OR) last released its earnings results on Wednesday, May 6th. The basic materials company reported $0.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.34 by $0.06. The company had revenue of $102.83 million for the quarter, compared to analyst estimates of $103.27 million. OR Royalties had a net margin of 78.09% and a return on equity of 15.10%. On average, equities research analysts anticipate that OR Royalties Inc. will post 1.38 earnings per share for the current fiscal year.

OR Royalties Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Tuesday, June 30th will be issued a dividend of $0.065 per share. This is a boost from OR Royalties’s previous quarterly dividend of $0.06. The ex-dividend date is Tuesday, June 30th. This represents a $0.26 dividend on an annualized basis and a yield of 0.7%. OR Royalties’s dividend payout ratio (DPR) is currently 16.42%.

OR Royalties Company Profile

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.